Benitec Patents Upheld In Australia
News Sep 16, 2005
Benitec Ltd. has announced that the Australian Patent Office has completed its review of Benitec's issued patents and they have been upheld.
Sara Cunningham, Chief Executive Officer of Benitec Ltd., stated, "There has never been a doubt in our minds about the validity of our patents. In conjunction with the recent successful resolution of our contract dispute with Promega, this result will allow us to broadly license our issued patent estate and use any ensuing revenue to focus on developing RNA interference based therapeutics for the treatment of infectious diseases.”
He adds, “RNAi, as with any groundbreaking technology, has been the subject of enormous legal scrutiny. As pioneers in the field, we are delighted to see our patents emerge from this challenge both intact and strengthened."
Benitec notes that in response to a patent infringement suit filed in March 2004, a re-examination request was filed relating to Benitec's issued patents in Australia (Australian Patent No. 743316 and Australian Innovation Patent No. 2001100608).
The patents have been reviewed, published for opposition, and Benitec has received notice from the Australian Patent Office that both re-examination proceedings have been successfully concluded.
Schizophrenics' Blood Contains RNA From More MicrobesNews
The blood of schizophrenia patients features genetic material from more types of microorganisms than that of people without the debilitating mental illness, research at Oregon State University has found. What’s not known is whether that’s a cause or effect of the severe, chronic condition that strikes about one person in 100.READ MORE
Faulty Gene Leads to Alcohol-Induced Heart FailureNews
A faulty gene interacts with alcohol to accelerate heart failure in susceptible patients, a study suggests. This dangerous interaction can occur even when only moderate amounts of alcohol have been consumed.READ MORE
Genetic Diversity Helps Protect Against DiseaseNews
Why do populations have genetic diversity when 'Survival of the Fittest' suggests that only one gene pool should thrive? It's a question that is hard to answer experimentally. A new study looking at evolutionary change in real time in tiny fungal parasites may provide a solution.